VALUE-Dx initiative to tackle antimicrobial resistance in respiratory infections

  11 June 2023

Antibiotic overprescriptions, particularly for ARTIs, are a key contributor to AMR. Both the English Surveillance Program for Antimicrobial Utilization and Resistance (ESPAUR) and the Journal of the American Medical Association (JAMA) have reported studies where up to 50% of prescribed antibiotics for ARTIs in Europe and the US were unnecessary. Furthermore, instances of inappropriately prescribed therapies for ARTIs have been correlated with higher mortality rates.

Further reading: Clinical Trials Arena
Author(s): Clinical Trials Arena
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed